Proteomic profiling of the plasma of Gambian children with cerebral malaria
Name:
12936_2018_2487_MOESM1_ESM.docx
Size:
49.52Kb
Format:
Microsoft Word 2007
Description:
Supplemental files
Name:
12936_2018_2487_MOESM2_ESM.docx
Size:
93.79Kb
Format:
Microsoft Word 2007
Description:
Supplemental files
Type
ArticleAuthors
Moussa, Ehab M.Huang, Honglei
Thézénas, Marie L.
Fischer, Roman
Ramaprasad, Abhinay

Sisay-Joof, Fatou
Jallow, Muminatou
Pain, Arnab

Kwiatkowski, Dominic
Kessler, Benedikt M.
Casals-Pascual, Climent
KAUST Department
Biological and Environmental Sciences and Engineering (BESE) DivisionBioscience Program
King Abdulla University of Science and Technology, Thuwal, Saudi Arabia.
Date
2018-09-24Online Publication Date
2018-09-24Print Publication Date
2018-12Permanent link to this record
http://hdl.handle.net/10754/628920
Metadata
Show full item recordAbstract
Cerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection. A number of pathological findings have been correlated with pediatric CM including sequestration, platelet accumulation, petechial haemorrhage and retinopathy. However, the molecular mechanisms leading to death in CM are not yet fully understood.A shotgun plasma proteomic study was conducted using samples form 52 Gambian children with CM admitted to hospital. Based on clinical outcome, children were assigned to two groups: reversible and fatal CM. Label-free liquid chromatography-tandem mass spectrometry was used to identify and compare plasma proteins that were differentially regulated in children who recovered from CM and those who died. Candidate biomarkers were validated using enzyme immunoassays.The plasma proteomic signature of children with CM identified 266 proteins differentially regulated in children with fatal CM. Proteins from the coagulation cascade were consistently decreased in fatal CM, whereas the plasma proteomic signature associated with fatal CM underscored the importance of endothelial activation, tissue damage, inflammation, haemolysis and glucose metabolism. The concentration of circulating proteasomes or PSMB9 in plasma was not significantly different in fatal CM when compared with survivors. Plasma PSMB9 concentration was higher in patients who presented with seizures and was significantly correlated with the number of seizures observed in patients with CM during admission.The results indicate that increased tissue damage and hypercoagulability may play an important role in fatal CM. The diagnostic value of this molecular signature to identify children at high risk of dying to optimize patient referral practices should be validated prospectively.Citation
Moussa EM, Huang H, Thézénas ML, Fischer R, Ramaprasad A, et al. (2018) Proteomic profiling of the plasma of Gambian children with cerebral malaria. Malaria Journal 17. Available: http://dx.doi.org/10.1186/s12936-018-2487-y.Sponsors
MalariaGEN’s primary funding is from the Wellcome Trust (Grant Number 077383/Z/05/Z) and from the Bill & Melinda Gates Foundation, through the Foundation for the National Institutes of Health (Grant Number 566) as part of the Grand Challenges in Global Health initiative. Wellcome Trust [Grant 090532/Z/09/Z (core facilities Wellcome Trust Centre for Human Genetics)]; C.C-P is supported by the Medical Research Council (Clinician Scientist Fellowship: G0701885).Publisher
Springer NatureJournal
Malaria JournalRelations
Is Supplemented By:- [Dataset]
. DOI: 10.6084/m9.figshare.c.4242833.v1 HANDLE: 10754/664217
- [Dataset]
. DOI: 10.6084/m9.figshare.7125641.v1 HANDLE: 10754/664218
- [Dataset]
. DOI: 10.6084/m9.figshare.7125623.v1 HANDLE: 10754/664219
ae974a485f413a2113503eed53cd6c53
10.1186/s12936-018-2487-y
Scopus Count
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.